|
1
|
Biber A, Harel R, Schwartz E. Further observation of travellers taking twice-weekly atovaquone-proguanil prophylaxis in sub-Saharan Africa. J Travel Med 2019; 26:5255712. [PMID: 30690466 DOI: 10.1093/jtm/tay156] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/13/2018] [Revised: 12/17/2018] [Accepted: 12/19/2018] [Indexed: 11/14/2022]
Affiliation(s)
- Asaf Biber
- The Center for Geographic Medicine and Tropical Diseases, The Chaim Sheba Medical Center, Tel Hashomer, Israel
| | - Reut Harel
- Internal Medicine C, Haemek Medical Center, Afula, Israel
| | - Eli Schwartz
- The Center for Geographic Medicine and Tropical Diseases, The Chaim Sheba Medical Center, Tel Hashomer, Israel
| |
Collapse
|
|
2
|
Meltzer E, Schwartz E. Atovaquone-proguanil chemoprophylaxis in the era of Tafenoquine. J Travel Med 2019; 26:5238719. [PMID: 30535377 DOI: 10.1093/jtm/tay133] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/11/2018] [Revised: 11/19/2018] [Accepted: 12/10/2018] [Indexed: 11/13/2022]
Affiliation(s)
- Eyal Meltzer
- From the Center for Geographic Medicine and Department of Medicine C at the Sheba Medical Center, Tel Hashomer, Israel.,Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - Eli Schwartz
- From the Center for Geographic Medicine and Department of Medicine C at the Sheba Medical Center, Tel Hashomer, Israel.,Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
| |
Collapse
|